SENORES PHARMACEUTICALS L Cash Flow-to-Debt Ratio
SENORES PHARMACEUTICALS L cash flow-to-debt ratio. SENORES PHARMACEUTICALS L (SENORES) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of Rs242.20 Million could theoretically repay 0% of its total liabilities (Rs4.54 Billion) in one year. Check SENORES cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of SENORES PHARMACEUTICALS L (2022–2026)
Cash flow-to-debt ratio of SENORES PHARMACEUTICALS L from 2022 to 2026. Historical debt coverage capacity for SENORES PHARMACEUTICALS L across 5 annual periods. Check SENORES PHARMACEUTICALS L (SENORES) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
SENORES PHARMACEUTICALS L Cash Flow-to-Debt Ratio by Year (2022–2026)
SENORES PHARMACEUTICALS L cash flow-to-debt ratio by year from 2022 to 2026. Year-by-year debt coverage analysis for SENORES PHARMACEUTICALS L. For the full cash flow conversion analysis, see cash efficiency ratio of SENORES PHARMACEUTICALS L.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | 0.10x | Rs620.50 Million | Rs6.39 Billion | ▲ +101.1% |
| 2025 | -9.06x | Rs-459.20 Million | Rs50.70 Million | ▼ -13650.2% |
| 2024 | -0.07x | Rs-257.00 Million | Rs3.90 Billion | ▼ -422.3% |
| 2023 | -0.01x | Rs-10.79 Million | Rs855.54 Million | ▲ +97.3% |
| 2022 | -0.46x | Rs-104.47 Million | Rs225.62 Million | — |